Analysis: Relaxo Footwears Limited

NSE:RELAXO Footwear Market cap: ₹8.6K cr

Growth thesis

Relaxo Footwears Ltd is an Indian footwear manufacturer with 70% men's, 25% women's, and 5% kids' revenue, operating through open (80%) and closed footwear (20%) segments. Growth hinges on 100 new EBOs by December 2026, premiumization via INR2,800+ athleisure/sneakers, and GST 2.0 (5% tax rate) to capture unorganized sector share. FY27 targets include 4-5% volume growth, 14-15% operating margins, and 25%+ EBO revenue contribution. Critical execution risks include delayed inventory destocking (45 days of stock), distributor rationalization challenges, and reliance on secondary sales growth through the Relaxo Parivaar app (now 60% of revenue). Past guidance misses (e.g., FY25 revenue decline despite 55% capacity utilization) highlight execution consistency concerns.

Why is Relaxo Footwears Limited stock rising?

  • Opening 100 new exclusive brand outlets (EBOs) in FY27, expanding to West and South India
  • Capex guidance of INR180-200 crore for FY27, including new store formats and molds
  • Premiumization via athleisure/sneakers at higher MRPs up to INR2,800, while retaining base at INR999
  • Increasing focus on women and kids categories to raise their contribution from current 25% and 5% respectively
  • Targeting operating margin expansion of ~1% in FY27 from 13.8% in FY26

Research report

Relaxo Footwears Ltd is a Fortune 500 (India) company and the largest manufacturer of non-leather footwear in India. The business began as a manufacturer of rubber-based hawai slippers - the thin, flat, everyday sandal that dominates Indian mass consumption - and built its early scale on this single product line. In FY05, the company launched two premium flagship brands, Sparx and Flite, marking a deliberate shift upmarket from commodity slippers into branded, higher-ASP footwear. That pivot is ...

Read the full report →

Catalysts

capex, margin expansion, geographic expansion

Growth guidance

FY27 volume growth guided at 4-5% driven by EBO expansion and premiumization initiatives

Guidance no_data

Management consistency

hype man

RS rating: 18 Stage: Stage 3

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Relaxo Footwears Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.
More in Footwear